AbbVie Inc., an Abbott Laboratories spin-off, has recalled more than 28,520 bottles of the thyroid-hormone replacement therapy Synthroid over a labeling error. It is ...

Manufacturing problems have led to the recall of the thyroid-hormone replacement therapy Synthroid for the second time in 6 months. This time, however, the responsibility for the return of more ...

Less than three weeks old, and AbbVie ($ABBV) has announced its first recall. The company said it recently pulled more than 28,500 bottles of the thyroid drug ...

The hypothyroid medication levothyroxine (Synthroid, AbbVie) continues to be the nation's most prescribed drug, and the antipsychotic aripiprazole (Abilify, Otsuka Pharmaceutical) continues to ...

The manufacturer of Synthroid, AbbVie, may provide a coupon, copay card, or a savings program. To learn more, visit the program website. You can also talk with your doctor or pharmacist for more ...

Hypothyroid medication levothyroxine (Synthroid, AbbVie) was the nation's most prescribed drug in 2013, whereas the antipsychotic aripiprazole (Abilify, Otsuka Pharmaceutical) had the highest ...

Neither Abbvie nor its former parent company ... including the popular thyroid treatment Synthroid and other prescription medicines that have generated billions of dollars in sales over the ...

AbbVie, which said it is launching with an ... Lupron, Synagis, Creon, Synthroid, Kaletra, Norvir and Zemplar. Its pipeline includes more than 20 mid- to late-stage clinical programs to address ...

AbbVie Inc., the Abbott Laboratories spinoff, has recalled more than 28,520 bottles of the thyroid-hormone replacement therapy Synthroid over a labeling error. It is ...